Please provide your email address to receive an email when new articles are posted on . LNZ100 improved near vision by at least two lines in 91% of participants. LNZ100 also improved distance vision.

Viatris Inc. (NASDAQ:VTRS) and Opus Genetics, Inc. (NASDAQ:IRD) revealed topline results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for ...

A new eye drop, Vizz, was recently FDA approved and is helping people regain near vision without glasses. Originally used for glaucoma, the drops are now repurposed for presbyopia (age-related ...

Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity that sends people reaching for stronger reading glasses every few years. With ...

Please provide your email address to receive an email when new articles are posted on . The study investigated Qlosi’s (pilocarpine hydrochloride ophthalmic solution 0.4%, Orasis Pharmaceuticals) ...

Presbyopia is defined as age-related loss of near vision that affects nearly everyone over age 45. The FDA has approved Vizz, an aceclidine ophthalmic solution 1.44%, making it the first and only ...

The FDA has approved a first-of-its-kind eye drop that addresses a common vision condition. The once-daily drops will treat an age-related condition that causes blurry near vision. The drops are ...